| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/08/2011 | CN1651451B 20(SO)ortho ginseng diol derivative, medicinal composition containing them and its application |
| 06/08/2011 | CN1511141B Method for preparation of 10,11-dihydro-10-hydroxy-5H-dibenz/B, F/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B, F/azepine-5-carboxamide |
| 06/08/2011 | CN102089429A Compositions and methods for inhibiting expression of TGF-beta receptor genes |
| 06/08/2011 | CN102089318A Salts of HIV inhibitor compounds |
| 06/08/2011 | CN102089314A Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| 06/08/2011 | CN102089313A 9-substituted-b-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| 06/08/2011 | CN102089312A Salinosporamide derivatives as proteasome inhibitors |
| 06/08/2011 | CN102089309A Pyrrolobenzodiazepines |
| 06/08/2011 | CN102089308A PI3K isoform selective inhibitors |
| 06/08/2011 | CN102089307A Pyrrolopyridines as kinase inhibitors |
| 06/08/2011 | CN102089306A Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds |
| 06/08/2011 | CN102089305A Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido [3, 2, 1-iJ] quinoline compounds |
| 06/08/2011 | CN102089304A Quinuclidine derivatives as muscarinic M3 receptor antagonists |
| 06/08/2011 | CN102089303A Nitrogenated heterocyclic compound |
| 06/08/2011 | CN102089302A Nitrogenated bicyclic heterocyclic compound |
| 06/08/2011 | CN102089301A Piperidine gpcr agonists |
| 06/08/2011 | CN102089300A Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 06/08/2011 | CN102089299A Piperidinyl gpcr agonists |
| 06/08/2011 | CN102089298A Heterocyclic gpcr agonists |
| 06/08/2011 | CN102089296A Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| 06/08/2011 | CN102089295A Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 06/08/2011 | CN102089291A Cyclopentylacrylic acid amide derivative |
| 06/08/2011 | CN102089290A Triazole derivatives useful for the treatment of diseases |
| 06/08/2011 | CN102089289A Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 06/08/2011 | CN102089287A Tetrahydrocinnolines as 11 beta HSD1 inhibitors for diabetes |
| 06/08/2011 | CN102089286A Chemical compounds |
| 06/08/2011 | CN102089285A Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 06/08/2011 | CN102089278A Compounds and compositions useful for the treatment of malaria |
| 06/08/2011 | CN102089277A Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 06/08/2011 | CN102089262A Derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof |
| 06/08/2011 | CN102089016A Implant and method for the manufacture thereof |
| 06/08/2011 | CN102089010A Dicabba-analogues of octreotide |
| 06/08/2011 | CN102089007A Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathway |
| 06/08/2011 | CN102089006A Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent |
| 06/08/2011 | CN102089001A Immunity-inducing agent and method for detection of cancer |
| 06/08/2011 | CN102088993A Methods of treating inflammation |
| 06/08/2011 | CN102088991A Metal abstraction peptide (MAP) tag and associated methods |
| 06/08/2011 | CN102088988A Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances |
| 06/08/2011 | CN102088984A Eradicating agent and eradication method for helicobacter pylori |
| 06/08/2011 | CN102088983A Treatment of cancers of the blood using selected glycomimetic compounds |
| 06/08/2011 | CN102088982A Preparation of intermediates useful in the syntheis of 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosylcytosine |
| 06/08/2011 | CN102088981A Sialic acid to support salivation |
| 06/08/2011 | CN102088980A 9-alpha estratriene derivatives as ER-beta selective ligands for the prevention and treatment of intestinal cancer |
| 06/08/2011 | CN102088979A Fumarate salt of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin-4-yl] oxy}quinazoline |
| 06/08/2011 | CN102088978A Ameliorating or therapeutic agent for dyslipidemia |
| 06/08/2011 | CN102088977A Cardioplegia solution for cardiac surgery |
| 06/08/2011 | CN102088976A Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist |
| 06/08/2011 | CN102088975A Pharmaceutical compositions based on kinin B2 receptor antagonists and corticosteroids, and their use |
| 06/08/2011 | CN102088974A Treatment of bladder diseases with a tlr7 activator |
| 06/08/2011 | CN102088973A Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 06/08/2011 | CN102088971A Use of tocotrienol composition for the prevention of cancer |
| 06/08/2011 | CN102088970A Improving renal function with quercetin-containing compositions |
| 06/08/2011 | CN102088969A Combination of spacitabine (CNDAC) and DNA methyltransferase inhibitors such as decitabine and procaine |
| 06/08/2011 | CN102088968A Blood substitute solution |
| 06/08/2011 | CN102088967A Therapy regimen for treating acne related diseases |
| 06/08/2011 | CN102088966A Pharmaceutical formulation |
| 06/08/2011 | CN102088965A Salicylate conjugates useful for treating metabolic disorders |
| 06/08/2011 | CN102088964A Electrostatically charged multi-acting nasal application, product, and method |
| 06/08/2011 | CN102088961A Eprosartan compositions |
| 06/08/2011 | CN102088960A Drug delivery carrier |
| 06/08/2011 | CN102088957A Topical composition for the treatment of actinic keratosis |
| 06/08/2011 | CN102088956A Proguanil to treat skin/mucosal diseases |
| 06/08/2011 | CN102088954A An intrauterine delivery system for contraception |
| 06/08/2011 | CN102088872A Sialic acid to support the immune system in the elderly |
| 06/08/2011 | CN102088871A Nutritional composition containing oligosaccharide mixture |
| 06/08/2011 | CN102088867A Composition of soluble indigestible fibre and of microalgae used in the well-being field |
| 06/08/2011 | CN102088859A Antimicrobial composition |
| 06/08/2011 | CN102088855A 2-aryl glycinamide derivatives |
| 06/08/2011 | CN102088854A Pharmaceutical compounds as cytotoxic agents and the use thereof |
| 06/08/2011 | CN102088853A Compounds for improving learning and memory |
| 06/08/2011 | CN102088850A Salts of methyl 2-((R))-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate |
| 06/08/2011 | CN102088849A Allosteric enhancers of the A1 adenosine receptor |
| 06/08/2011 | CN102088848A Anti-bacterial activity of 9-hydroxy derivatives of 6, 11-bicyclolides |
| 06/08/2011 | CN102086239A Preparation method of silkworm chrysalis chitosan derivatives with anticoagulation activities |
| 06/08/2011 | CN102086221A Sugar bis-aryl triazole compounds with antimicrobial activity, and synthesis method and medicinal use thereof |
| 06/08/2011 | CN102086212A Antifungal agents of 2,3,4,5-tetrahydro-4H-benzo[b]thiopyrano[4,3,c]pyrazole-2-formamide derivatives |
| 06/08/2011 | CN102086211A Aromatic heterocyclic compounds serving as protein kinase inhibitor |
| 06/08/2011 | CN102086207A Camptothecin derivative with antitumor activity |
| 06/08/2011 | CN102086197A Protoberberine derivative with insulin-sensitizing activity and application thereof |
| 06/08/2011 | CN102086195A Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof |
| 06/08/2011 | CN102086193A N-substituted alpha-amino acid derivatives and preparation method and application thereof |
| 06/08/2011 | CN102086192A Medicament for infrasound damage prevention |
| 06/08/2011 | CN102086185A Oligomeric proanthocyanidins and method for extracting same |
| 06/08/2011 | CN102086182A Petasites tatewakianus Kitam. extract as well as preparation method and application thereof |
| 06/08/2011 | CN102086178A Cinepazide maleate disesquihydrate and preparation method thereof |
| 06/08/2011 | CN102086172A Medicinal salts of saxagliptin and preparation methods of medicinal salts |
| 06/08/2011 | CN102086166A 3-methoxy-4-(N-substituted amino sulfonyl)fenalamide compounds and application thereof |
| 06/08/2011 | CN102086150A Seven-layer tower extract and extraction method thereof, and seven-layer tower extract-containing component |
| 06/08/2011 | CN102085378A Application of hfgl2 (Human Fibrinogen-like protein 2) inhibitor in preparation of medicaments for treating liver cancer |
| 06/08/2011 | CN102085376A Phospholipid complex of gentian total glucosides and preparation method thereof |
| 06/08/2011 | CN102085374A Asarin medical composition, preparation method and application thereof |
| 06/08/2011 | CN102085373A Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 06/08/2011 | CN102085372A Application of Notch pathway inhibitor in treatment of tumors caused by activation of mTOR |
| 06/08/2011 | CN102085371A Medical gargle product for Xerostomia and preparation method thereof |
| 06/08/2011 | CN102085370A Oral spray for inflammatory diseases of oral cavity and preparation method thereof |
| 06/08/2011 | CN102085369A Medical gel product for xerostomia and preparation method thereof |
| 06/08/2011 | CN102085356A Composition for increasing bone mineral density and preparation method thereof |
| 06/08/2011 | CN102085323A Drug dripping pill with effects of preventing phlegm from forming and stopping coughing |